Nadia Belopolski

Nadia Belopolski is a seasoned professional in the field of regulatory affairs and quality assurance for medical devices, currently serving as the RA Lead at Neopharm Group since December 2015. In this role, Nadia supports regulatory activities, including product regulatory due diligence assessments, submission of registration files, license maintenance, and post-market regulatory activities. Prior to Neopharm Group, Nadia was a QA&RA Engineer at Trupharm Marketing from March 2012 to December 2015, focusing on quality system maintenance in compliance with ISO 13485, ISO 9001, and GMP standards, as well as overseeing regulatory affairs related to medical device submissions. Nadia holds a B.Sc. in Biochemical Engineering from the Technion - Israel Institute of Technology, earned from 2006 to 2010.